EE04414B1 - Tiotroopiumi sisaldav inhalatsioonipulber, meetodselle valmistamiseks ja selle kasutamine ravimi valmistamiseks - Google Patents

Tiotroopiumi sisaldav inhalatsioonipulber, meetodselle valmistamiseks ja selle kasutamine ravimi valmistamiseks

Info

Publication number
EE04414B1
EE04414B1 EEP200200428A EEP200200428A EE04414B1 EE 04414 B1 EE04414 B1 EE 04414B1 EE P200200428 A EEP200200428 A EE P200200428A EE P200200428 A EEP200200428 A EE P200200428A EE 04414 B1 EE04414 B1 EE 04414B1
Authority
EE
Estonia
Prior art keywords
medicament
manufacture
preparation
inhalation powder
tiotropium
Prior art date
Application number
EEP200200428A
Other languages
English (en)
Inventor
Bechtold-Peters Karoline
Walz Michael
Boeck Georg
D�rr Rolf
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04414(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200200428A publication Critical patent/EE200200428A/et
Publication of EE04414B1 publication Critical patent/EE04414B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP200200428A 2000-10-12 2001-09-28 Tiotroopiumi sisaldav inhalatsioonipulber, meetodselle valmistamiseks ja selle kasutamine ravimi valmistamiseks EE04414B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
PCT/EP2001/011227 WO2002030389A1 (de) 2000-10-12 2001-09-28 Neue tiotropium-haltige inhalationspulver

Publications (2)

Publication Number Publication Date
EE200200428A EE200200428A (et) 2003-02-17
EE04414B1 true EE04414B1 (et) 2005-02-15

Family

ID=7659578

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200428A EE04414B1 (et) 2000-10-12 2001-09-28 Tiotroopiumi sisaldav inhalatsioonipulber, meetodselle valmistamiseks ja selle kasutamine ravimi valmistamiseks

Country Status (49)

Country Link
US (4) US7070800B2 (et)
EP (2) EP1292281B1 (et)
JP (1) JP3870159B2 (et)
KR (1) KR100488644B1 (et)
CN (1) CN1210017C (et)
AP (1) AP1712A (et)
AR (1) AR031819A1 (et)
AT (1) ATE275391T1 (et)
AU (1) AU757008B2 (et)
BG (1) BG65753B1 (et)
BR (1) BR0107304A (et)
CA (1) CA2395653C (et)
CR (1) CR6937A (et)
CU (1) CU23284B7 (et)
CZ (1) CZ301465B6 (et)
DE (1) DE50103551C5 (et)
DK (1) DK1292281T3 (et)
DZ (1) DZ3477A1 (et)
EA (1) EA004034B1 (et)
EC (2) ECSP024268A (et)
EE (1) EE04414B1 (et)
EG (1) EG24139A (et)
ES (1) ES2227268T3 (et)
GE (1) GEP20063865B (et)
HK (1) HK1051812A1 (et)
HR (1) HRP20020437B1 (et)
HU (1) HU226982B1 (et)
IL (2) IL149984A0 (et)
IS (1) IS2360B (et)
MA (1) MA25843A1 (et)
ME (2) ME00245B (et)
MX (1) MXPA02005666A (et)
MY (1) MY123544A (et)
NO (1) NO331956B1 (et)
NZ (1) NZ519406A (et)
OA (1) OA12522A (et)
PE (1) PE20020577A1 (et)
PL (1) PL200063B1 (et)
PT (1) PT1292281E (et)
RS (1) RS50197B (et)
SA (1) SA01220460B1 (et)
SI (1) SI1292281T1 (et)
SK (1) SK285389B6 (et)
TR (1) TR200402367T4 (et)
TW (1) TWI285553B (et)
UA (1) UA72014C2 (et)
UY (1) UY26959A1 (et)
WO (1) WO2002030389A1 (et)
ZA (1) ZA200204378B (et)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50103551C5 (de) * 2000-10-12 2014-08-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue tiotropium-haltige inhalationspulver
EP1920763B2 (en) 2000-11-30 2022-06-15 Vectura Limited Pharmaceutical compositions for inhalation
EP2168571B1 (en) 2000-11-30 2018-08-22 Vectura Limited Particles for use in a Pharmaceutical Composition
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10128779A1 (de) * 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma Verfahren zur Reinigung von Hartgelatinekapseln
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
BR0308984A (pt) * 2002-04-04 2005-02-09 Boehringer Ingelheim Pharma Formulações em pó adequadas para inalação
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
JP2006504666A (ja) * 2002-06-12 2006-02-09 エピジェネシス ファーマシューティカルズ リミティド ライアビリティー カンパニー デヒドロエピアンドロステロン・ステロイド及び抗ムスカリン薬で呼吸器及び肺の疾患を治療するための組成物、配合物及びキット
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
JP2006516531A (ja) * 2002-08-21 2006-07-06 ノートン　ヘルスケアー　リミテッド 吸入組成物
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US20050058606A1 (en) * 2002-12-16 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing HFC solution formulations
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
ES2872350T3 (es) 2003-06-13 2021-11-02 Civitas Therapeutics Inc Polvos farmacéuticos de dosis baja para inhalación
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
ES2350981T3 (es) 2003-11-03 2011-01-28 Boehringer Ingelheim International Gmbh Procedimiento para la preparación de nuevas sales de tiotropio.
ATE460414T1 (de) 2003-11-03 2010-03-15 Boehringer Ingelheim Int Verfahren zur herstellung von tiotropiumsalzen
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
EP1691783B1 (en) * 2003-12-03 2009-11-25 Boehringer Ingelheim International GmbH Pre-metered dry powder inhaler for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
EP1848444B1 (en) 2005-02-10 2016-11-09 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
CN101166738B (zh) * 2005-05-02 2011-06-01 贝林格尔·英格海姆国际有限公司 噻托溴铵的新晶型
JP5315048B2 (ja) * 2005-06-15 2013-10-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規チオトロピウム塩の製造方法、新規チオトロピウム塩及びその医薬組成物
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
CN101360744A (zh) * 2005-12-19 2009-02-04 西科尔公司 纯和稳定的噻托溴铵
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
PL1869035T5 (pl) * 2005-12-19 2016-01-29 Sicor Inc Nowa postać krystaliczna bromku tiotropium i proces jej wytwarzania
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
CN103691530A (zh) * 2007-07-27 2014-04-02 卡吉尔公司 多元醇的微粉化
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
CN102014779B (zh) 2008-05-09 2014-10-22 赫莱拉公司 用于治疗支气管树的系统、组件和方法
EP2172190A1 (en) 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
SG174389A1 (en) 2009-03-17 2011-10-28 Daiichi Sankyo Co Ltd Amide derivative
CN112089394A (zh) 2009-10-27 2020-12-18 努瓦拉公司 具有可冷却的能量发射组件的递送装置
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
WO2011060200A1 (en) 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
US9259376B2 (en) 2010-06-03 2016-02-16 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2014007773A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2522213C2 (ru) * 2012-06-07 2014-07-10 Шолекс Девелопмент Гмбх, Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащих в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
US10105316B2 (en) * 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
WO2014007770A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
UA115989C2 (uk) 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
WO2014007781A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
WO2014007772A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
US20150174064A1 (en) * 2012-07-05 2015-06-25 Arven IIac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and glucose anhydrous
EP2705838A1 (en) 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
DK3159277T3 (da) 2015-10-23 2019-09-02 Arven Ilac Sanayi Ve Ticaret As Blister til inhalerbar formulering af tiotropiumbromid
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
BR112018010685A8 (pt) * 2015-12-24 2019-02-26 Philip Morris Products Sa nicotina em pó aromatizada
CN110505876A (zh) 2017-03-23 2019-11-26 新加坡保健服务集团 包含噻托铵作为活性成分的用于预防近视、治疗近视、及/或预防近视进展的药剂
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation
GR1010358B (el) * 2021-09-14 2022-12-16 Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
JPS60172442A (ja) 1984-02-20 1985-09-05 Fanuc Ltd ならい加工およびνｃ加工による機械加工装置
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
ATE170745T1 (de) 1991-04-08 1998-09-15 Nippon Shinyaku Co Ltd Kapsel mit langzeitwirkung fuer die adhäsion im gastrointestinaltrakt
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
US5819730A (en) 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
DE69435104D1 (de) 1993-09-28 2008-07-31 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
DK1283036T3 (da) 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
US20040002548A1 (en) 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
JP3931486B2 (ja) 1999-06-24 2007-06-13 住友化学株式会社 ポジ型レジスト組成物
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
DE50103551C5 (de) 2000-10-12 2014-08-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue tiotropium-haltige inhalationspulver
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US20030070679A1 (en) 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US6482429B1 (en) 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
BR0308984A (pt) 2002-04-04 2005-02-09 Boehringer Ingelheim Pharma Formulações em pó adequadas para inalação
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation

Also Published As

Publication number Publication date
DZ3477A1 (et) 2002-04-18
AP1712A (en) 2007-01-24
HK1051812A1 (en) 2003-08-22
EG24139A (en) 2008-08-06
HRP20020437B1 (en) 2005-10-31
SI1292281T1 (en) 2004-12-31
HUP0203885A2 (hu) 2003-03-28
CA2395653C (en) 2006-05-09
NO331956B1 (no) 2012-05-14
MEP40108A (en) 2011-02-10
KR20020063912A (ko) 2002-08-05
ATE275391T1 (de) 2004-09-15
PL356840A1 (en) 2004-07-12
SA01220460B1 (ar) 2006-10-31
CR6937A (es) 2003-11-28
PE20020577A1 (es) 2002-08-08
EP1292281A1 (de) 2003-03-19
NO20022414D0 (no) 2002-05-22
ECSP024268A (es) 2002-08-01
CZ20021785A3 (cs) 2002-09-11
ECSP034546A (es) 2003-06-25
DK1292281T3 (da) 2004-10-11
EA004034B1 (ru) 2003-12-25
SK7062002A3 (en) 2002-10-08
CZ301465B6 (cs) 2010-03-10
JP3870159B2 (ja) 2007-01-17
AU8993501A (en) 2002-04-22
HRP20020437A2 (en) 2004-08-31
UY26959A1 (es) 2002-06-20
AP2003002774A0 (en) 2003-03-31
CN1392795A (zh) 2003-01-22
DE50103551C5 (de) 2014-08-21
AU757008B2 (en) 2003-01-30
IL149984A (en) 2007-06-03
RS50197B (sr) 2009-05-06
PL200063B1 (pl) 2008-12-31
SK285389B6 (sk) 2006-12-07
CA2395653A1 (en) 2002-04-18
CU23284B7 (es) 2008-06-30
AR031819A1 (es) 2003-10-08
EP1292281B1 (de) 2004-09-08
PT1292281E (pt) 2004-11-30
BR0107304A (pt) 2002-08-13
ME00245B (me) 2011-02-10
MXPA02005666A (es) 2002-11-29
NO20022414L (no) 2002-05-30
HU226982B1 (en) 2010-04-28
TR200402367T4 (tr) 2004-12-21
OA12522A (en) 2006-05-30
EA200200551A1 (ru) 2002-12-26
CN1210017C (zh) 2005-07-13
ZA200204378B (en) 2003-05-19
IS6771A (is) 2003-04-08
JP2004510805A (ja) 2004-04-08
WO2002030389A1 (de) 2002-04-18
KR100488644B1 (ko) 2005-05-11
DE50103551D1 (de) 2004-10-14
UA72014C2 (en) 2005-01-17
MY123544A (en) 2006-05-31
IS2360B (is) 2008-05-15
BG106730A (bg) 2003-03-31
EE200200428A (et) 2003-02-17
BG65753B1 (bg) 2009-10-30
IL149984A0 (en) 2002-12-01
NZ519406A (en) 2003-07-25
EP1430887A1 (de) 2004-06-23
US20060039868A1 (en) 2006-02-23
GEP20063865B (en) 2006-07-10
TWI285553B (en) 2007-08-21
US7070800B2 (en) 2006-07-04
US20040228806A1 (en) 2004-11-18
US20020110529A1 (en) 2002-08-15
US20080292563A1 (en) 2008-11-27
HUP0203885A3 (en) 2005-01-28
ES2227268T3 (es) 2005-04-01
MA25843A1 (fr) 2003-07-01
YU36302A (sh) 2002-09-19

Similar Documents

Publication Publication Date Title
EE04414B1 (et) Tiotroopiumi sisaldav inhalatsioonipulber, meetodselle valmistamiseks ja selle kasutamine ravimi valmistamiseks
EE05316B1 (et) Kristalliline antikolinergikum, meetod selle valmistamiseks ja selle kasutamine ravimi valmistamiseks
EE04567B1 (et) Kristalliline monohdraat, meetod selle valmistamiseks ja selle kasutamine ravimi valmistamiseks
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
EE05643B1 (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
PL387118A1 (pl) Kapsułki do inhalacji zawierające tiotropium i ich zastosowanie
HK1201447A1 (en) A dry powder formulation and method of making the same and use of the formulation in a dry powder inhaler
EG24478A (en) New inhalable powder containing tiotropium
EE200100375A (et) Telmisartaani polümorfid, meetodid nende valmistamiseks ja nende kasutamine ravimi valmistamiseks
EE200200602A (et) Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
IL153167A0 (en) Phenyl derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy
IL159275A0 (en) Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
MXPA03004936A (es) Compuestos ciclicos fusionados y uso medicinal de los mismos.
HRP20020968A2 (en) Acylphenyl urea derivatives, methods for the production therof and use thereof as a medicament
AU4671501A (en) Medical combinations comprising tiotropium and rofleponide
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
CZ20023753A3 (cs) Substituované thioacetamidy, jejich použití pro výrobu léčiva a farmaceutický prostředek s jejich obsahem
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU4854001A (en) Medical combinations comprising tiotropium and mometasone
HK1129111A1 (en) Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
HRP20041157B1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL181819A (en) Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds
EE200000796A (et) Ravimkuulike, selle valmistamismeetod ja farmatseutiline doseerimisvorm, ravimkuulikeste kasutaminefarmatseutilise doseerimisvormi valmistamiseks ning farmatseutiline pakend

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231